Evidence map›Paper›PMID 38222605›Full record

ArticleACS omega2024

Salicylic Acid Conjugate of Telmisartan Inhibits Chikungunya Virus Infection and Inflammation.

Rudra Narayan Dash, Amrita Ray, Prabhudutta Mamidi, Saikat De, Tapas K Mohapatra, Alok K Moharana, Tathagata Mukherjee, Soumyajit Ghosh, Subhasis Chattopadhyay, Bharat B Subudhi and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Network Pharmacology, Molecular Docking andCurrent computer-aided drug design · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Rudra Narayan DashDrug Development and Analysis Lab, School of Pharmaceutical Sciences, Siksha O Anusandhan Deemed to be University, Kalinga Nagar, Bhubaneswar 751003, Odisha, India.ORCID https://orcid.org/0000-0002-9760-0808
Amrita RayInfectious Disease Biology, Institute of Life Sciences, NALCO square, Bhubaneswar 751023,Odisha, India.ORCID https://orcid.org/0000-0001-5220-9402
Prabhudutta MamidiInfectious Disease Biology, Institute of Life Sciences, NALCO square, Bhubaneswar 751023,Odisha, India.
Saikat DeInfectious Disease Biology, Institute of Life Sciences, NALCO square, Bhubaneswar 751023,Odisha, India.ORCID https://orcid.org/0000-0003-2028-0428
Tapas K MohapatraDrug Development and Analysis Lab, School of Pharmaceutical Sciences, Siksha O Anusandhan Deemed to be University, Kalinga Nagar, Bhubaneswar 751003, Odisha, India.ORCID https://orcid.org/0000-0003-4754-8973
Alok K MoharanaDrug Development and Analysis Lab, School of Pharmaceutical Sciences, Siksha O Anusandhan Deemed to be University, Kalinga Nagar, Bhubaneswar 751003, Odisha, India.ORCID https://orcid.org/0000-0002-6169-6000
Tathagata MukherjeeSchool of Biological Sciences, National Institute of Science Education and Research, HBNI, 752050 Bhubaneswar, India.ORCID https://orcid.org/0000-0001-7504-5957
Soumyajit GhoshInfectious Disease Biology, Institute of Life Sciences, NALCO square, Bhubaneswar 751023,Odisha, India.ORCID https://orcid.org/0000-0003-3991-3010
Subhasis ChattopadhyaySchool of Biological Sciences, National Institute of Science Education and Research, HBNI, 752050 Bhubaneswar, India.ORCID https://orcid.org/0000-0002-2596-8451
Bharat B SubudhiDrug Development and Analysis Lab, School of Pharmaceutical Sciences, Siksha O Anusandhan Deemed to be University, Kalinga Nagar, Bhubaneswar 751003, Odisha, India.ORCID https://orcid.org/0000-0002-2411-7292
Soma ChattopadhyayInfectious Disease Biology, Institute of Life Sciences, NALCO square, Bhubaneswar 751023,Odisha, India.ORCID https://orcid.org/0000-0001-8378-1014
National Institute of Science Education and Research · INRegional Centre for Biotechnology · INSiksha O Anusandhan University · INAll India Institute of Medical Sciences Bhubaneswar · INJain University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is no approved antiviral for the management of the Chikungunya virus (CHIKV). To develop an antiviral drug that can manage both CHIKV and arthritis induced by it, an ester conjugate of telmisartan (TM) and salicylic acid (SA) was synthesized (DDABT1). It showed higher potency (IC

Identifiers

PMID38222605
PMCPMC10785651
OpenAlexW4390082948

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.